Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 106   

Articles published

JNJ 101.97 -0.03 (-0.03%)
price chart
Local Johnson & Johnson move affects 127 employees
8, the Memphis Business Journal broke the news that Johnson & Johnson is transitioning its local distribution operations to GENCO, a Pittsburgh-based third-party logistics company that was recently acquired by FedEx Corp.
Johnson & Johnson hires FedEx's GENCO to run Memphis center  Memphis Commercial Appeal
FedEx's GENCO to Take Over J&J Memphis Logistic Operations?  Bidness ETC
Healthcare Intelligence: Johnson & Johnson Is Finally In The Hotseat
Johnson & Johnson (NYSE:JNJ) is the leading health conglomerate we can learn from. Investors should always observe industry leaders to understand the market's pros and cons.
FedEx company to take over Johnson & Johnson Memphis operations
Johnson & Johnson Health Care Systems' Memphis distribution center is transitioning operations to a third-party logistics company that FedEx Corp.
FedEx company taking over Memphis logistics from J&J  Seeking Alpha
Biogen Inc. Takes Aim at Johnson & Johnson
The launch of a biosimilar to Johnson & Johnson's (NYSE:JNJ) top-selling Remicade this year is a key goal of a joint venture between Biogen Inc. (NASDAQ:BIIB) and South Korea-based Samsung.
Johnson & Johnson to Participate in RBC Capital Markets Global Healthcare ...
NEW BRUNSWICK, N.J., Feb. 9, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, Feb. 23, at the New York Palace in New York City.
Developing vaccine for Zika to take time: Johnson & Johnson's Paul Stoffels
MUMBAI: A Zika vaccine may still be a long way off because of the complications involved in identifying the virus, which has so far not been studied by virologists, said Paul Stoffels, chief scientific officer of US drug maker Johnson & Johnson. "The ...
Johnson & Johnson (JNJ) Closes 0.15% Up on the Day for February 09
Dow Jones component Johnson & Johnson (JNJ) saw its stock move 0.15% to $102.15, representing a per-share move of $0.15, on volume of 7.23 million shares for Tuesday.
Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte ...
Johnson & Johnson (J&J), like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1 diabetes treatment.
Johnson & Johnson, ViaCyte testing possible diabetes cure  Waterbury Republican American
Johnson & Johnson CEO buys $9 million Manhattan condo
Alex Gorsky, the CEO of Johnson & Johnson, and his wife, Patricia, bought a $9 million condo at One Riverside Park, an Extell Development project at 50 Riverside Drive - well over its $8.86 million asking price, according to city property records.
Why Isn't Johnson & Johnson Making More Acquisitions?
A massive and uncharacteristically high cash stockpile has Johnson & Johnson's (NYSE:JNJ) management discussing how best to spend its money.